Toshikatsu Hanada

10.8k total citations · 5 hit papers
64 papers, 7.2k citations indexed

About

Toshikatsu Hanada is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Toshikatsu Hanada has authored 64 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 26 papers in Immunology and 24 papers in Molecular Biology. Recurrent topics in Toshikatsu Hanada's work include Cytokine Signaling Pathways and Interactions (27 papers), interferon and immune responses (11 papers) and RNA modifications and cancer (7 papers). Toshikatsu Hanada is often cited by papers focused on Cytokine Signaling Pathways and Interactions (27 papers), interferon and immune responses (11 papers) and RNA modifications and cancer (7 papers). Toshikatsu Hanada collaborates with scholars based in Japan, Austria and United States. Toshikatsu Hanada's co-authors include Akihiko Yoshimura, Masato Kubo, Daisuke Aki, Hideo Yasukawa, Hiroyuki Mori, Masanobu Ohishi, Akihiko Yoshimura, Reiko Hanada, Takafumi Yoshida and Hitomi Nishinakamura and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Toshikatsu Hanada

63 papers receiving 7.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses

2010 819 citations Toshikatsu Hanada, Akihiko Yoshimura et al. profile →
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages

2003 647 citations Hideo Yasukawa, Masanobu Ohishi et al. Nature Immunology profile →
SOCS1/JAB Is a Negative Regulator of LPS-Induced Macrophage Activation

2002 540 citations Toshikatsu Hanada, Hiroyuki Mori et al. profile →
Suppressors of cytokine signaling and immunity

2003 538 citations Masato Kubo, Toshikatsu Hanada et al. Nature Immunology profile →
Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity

2004 517 citations Hiroyuki Mori, Reiko Hanada et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshikatsu Hanada Japan	33	3.6k	3.0k	2.2k	1.2k	798	64	7.2k
Hideo Yasukawa Japan	40	3.4k 0.9×	3.8k 1.3×	2.4k 1.1×	1.0k 0.9×	896 1.1×	77	8.4k
Fred Schaper Germany	40	4.3k 1.2×	5.0k 1.7×	3.3k 1.5×	1.2k 1.0×	1.0k 1.3×	96	9.9k
Lutz Graeve Germany	37	2.4k 0.7×	3.1k 1.0×	2.4k 1.1×	867 0.7×	543 0.7×	85	6.5k
Koichi Nakajima Japan	46	3.8k 1.1×	4.0k 1.3×	3.6k 1.7×	1.2k 1.0×	648 0.8×	95	9.4k
Christian Schindler United States	46	5.9k 1.6×	5.1k 1.7×	3.5k 1.6×	1.3k 1.1×	1.3k 1.7×	82	10.7k
Christoph Garbers Germany	40	2.8k 0.8×	2.7k 0.9×	1.9k 0.8×	662 0.5×	604 0.8×	118	6.4k
Heike M. Hermanns Germany	29	2.0k 0.5×	2.4k 0.8×	1.8k 0.8×	593 0.5×	932 1.2×	63	5.3k
Masato Kubo Japan	51	5.9k 1.6×	2.4k 0.8×	2.2k 1.0×	967 0.8×	572 0.7×	129	9.4k
Iris Behrmann Germany	46	4.4k 1.2×	5.0k 1.7×	5.9k 2.7×	1.9k 1.6×	1000 1.3×	92	11.6k
Tracy A. Willson Australia	43	4.3k 1.2×	5.2k 1.8×	4.8k 2.2×	1.0k 0.8×	904 1.1×	74	11.1k

Countries citing papers authored by Toshikatsu Hanada

Since Specialization

Citations

This map shows the geographic impact of Toshikatsu Hanada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshikatsu Hanada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshikatsu Hanada more than expected).

Fields of papers citing papers by Toshikatsu Hanada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshikatsu Hanada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshikatsu Hanada. The network helps show where Toshikatsu Hanada may publish in the future.

Co-authorship network of co-authors of Toshikatsu Hanada

This figure shows the co-authorship network connecting the top 25 collaborators of Toshikatsu Hanada. A scholar is included among the top collaborators of Toshikatsu Hanada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshikatsu Hanada. Toshikatsu Hanada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teranishi, Hitoshi, et al.. (2024). Behavioral and neurotransmitter changes on antiepileptic drugs treatment in the zebrafish pentylenetetrazol-induced seizure model. Behavioural Brain Research. 464. 114920–114920. 12 indexed citations

Shiraishi, Hiroshi, Nobuyuki Shimizu, Shinji Yano, et al.. (2024). Effect of nonsense-mediated mRNA decay factor SMG9 deficiency on premature aging in zebrafish. Communications Biology. 7(1). 654–654. 3 indexed citations

Miyahara, Hiroaki, Nobuyuki Shimizu, Hiroshi Shiraishi, et al.. (2024). Biallelic variants in LARS1 induce steatosis in developing zebrafish liver via enhanced autophagy. Orphanet Journal of Rare Diseases. 19(1). 219–219. 1 indexed citations

Shimizu, Nobuyuki, Hiroaki Miyahara, Hitoshi Teranishi, et al.. (2024). DHCR7 links cholesterol synthesis with neuronal development and axonal integrity. Biochemical and Biophysical Research Communications. 712-713. 149932–149932. 3 indexed citations

Shimizu, Nobuyuki, Koichi Honda, Hitoshi Teranishi, et al.. (2024). Hepatic extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease. Scientific Reports. 14(1). 7813–7813. 3 indexed citations

Shimizu, Nobuyuki, Hiroshi Shiraishi, & Toshikatsu Hanada. (2023). Zebrafish as a Useful Model System for Human Liver Disease. Cells. 12(18). 2246–2246. 32 indexed citations

SASAKI, Kazuaki, et al.. (2021). Control of Developmental Speed in Zebrafish Embryos Using Different Incubation Temperatures. Zebrafish. 18(5). 316–325. 12 indexed citations

Miyahara, Hiroaki, et al.. (2021). Metabolome Characteristics of Liver Autophagy Deficiency under Starvation Conditions in Infancy. Nutrients. 13(9). 3026–3026. 4 indexed citations

Hanada, Toshikatsu, Hitoshi Teranishi, Daisuke Miki, et al.. (2018). CD105 maintains the thermogenic program of beige adipocytes by regulating Smad2 signaling. Molecular and Cellular Endocrinology. 474. 184–193. 4 indexed citations

10.

Weitzer, Stefan, Toshikatsu Hanada, Josef Penninger, & Javier Martı̂nez. (2014). CLP1 as a novel player in linking tRNA splicing to neurodegenerative disorders. Wiley Interdisciplinary Reviews - RNA. 6(1). 47–63. 41 indexed citations

11.

Saeki, Kazuko, Satoru Fukuyama, Toranoshin Ayada, et al.. (2009). A Major Lipid Raft Protein Raftlin Modulates T Cell Receptor Signaling and Enhances Th17-Mediated Autoimmune Responses. The Journal of Immunology. 182(10). 5929–5937. 53 indexed citations

12.

Tanaka, Kentaro, Kenji Ichiyama, Masayuki Hashimoto, et al.. (2008). Loss of Suppressor of Cytokine Signaling 1 in Helper T Cells Leads to Defective Th17 Differentiation by Enhancing Antagonistic Effects of IFN-γ on STAT3 and Smads. The Journal of Immunology. 180(6). 3746–3756. 154 indexed citations

13.

Hanada, Toshikatsu, Kentaro Tanaka, Yumiko Matsumura, et al.. (2005). Induction of Hyper Th1 Cell-Type Immune Responses by Dendritic Cells Lacking the Suppressor of Cytokine Signaling-1 Gene. The Journal of Immunology. 174(7). 4325–4332. 87 indexed citations

14.

Takeda, Atsunobu, Shinjiro Hamano, Atsushi Yamanaka, et al.. (2003). Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment. The Journal of Immunology. 170(10). 4886–4890. 458 indexed citations

15.

Yasukawa, Hideo, Masanobu Ohishi, Hiroyuki Mori, et al.. (2003). IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nature Immunology. 4(6). 551–556. 647 indexed citations breakdown →

16.

Yoshimura, Akihiko, Hiroyuki Mori, Masanobu Ohishi, Daisuke Aki, & Toshikatsu Hanada. (2003). Negative regulation of cytokine signaling influences inflammation. Current Opinion in Immunology. 15(6). 704–708. 105 indexed citations

17.

Nomura, Takeo, et al.. (2002). Clinical significance of thymidylate synthase expression in bladder cancer. International Journal of Urology. 9(7). 368–376. 37 indexed citations

18.

Yoshida, Takafumi, Toshikatsu Hanada, Toru Wakioka, et al.. (2001). Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. Journal of Clinical Investigation. 108(12). 1781–1788. 331 indexed citations

19.

Hanada, Toshikatsu, Masayuki Nakagawa, Akio Emoto, et al.. (2000). Prognostic value of tumor‐associated macrophage count in human bladder cancer. International Journal of Urology. 7(7). 263–269. 232 indexed citations

20.

Nakagawa, Masayuki, Akio Emoto, Nobuyoshi Nasu, et al.. (1997). Clinical significance of multi-drug resistance associated protein and P-glycoprotein in patients with bladder cancer.. PubMed. 157(4). 1260–4; discussion 1264. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact